First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy. Janin, A., Bessière, F., Chauveau, S., Chevalier, P., & Millat, G. Gene, 676:110–116, November, 2018.
First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy [link]Paper  doi  abstract   bibtex   
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease with an estimated prevalence of 1/500. More than 40 genes have been reported to cause HCM. Among them, CSRP3 is usually included on HCM gene panels used for molecular diagnosis by next-generation sequencing (NGS). To provide new insights into the pathophysiology of hypertrophic cardiomyopathy, a NGS workflow based on a panel of 48 cardiomyopathies-causing genes was analyzed on a cohort of 542 HCM patients. As expected, this molecular approach led to identify most pathogenic or likely pathogenic variants into prevalent HCM-causing genes: MYBPC3 (123/542; 22.7%), MYH7 (48/542; 8.9%), TNNT2 (12/542; 2.2%), and TNNI3 (10/542; 1.8%). Among MYBPC3 variants, 96 led to a premature stop codon (78%). More surprisingly, our molecular study led also to detect, for the first time, homozygous CSRP3 truncating variants in two unrelated HCM probands. Meta-analysis of rare previously reported CSRP3 variants on HCM probands using ACMG guidelines indicate that only one variation (p.Cys58Gly) could be considered as likely pathogen. By combining meta-analysis results and identification of two unrelated HCM patients with homozygous CSRP3 truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an autosomal recessive inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124).
@article{janin_first_2018,
	title = {First identification of homozygous truncating {CSRP3} variants in two unrelated cases with hypertrophic cardiomyopathy},
	volume = {676},
	issn = {0378-1119},
	url = {http://www.sciencedirect.com/science/article/pii/S0378111918308102},
	doi = {10.1016/j.gene.2018.07.036},
	abstract = {Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease with an estimated prevalence of 1/500. More than 40 genes have been reported to cause HCM. Among them, CSRP3 is usually included on HCM gene panels used for molecular diagnosis by next-generation sequencing (NGS). To provide new insights into the pathophysiology of hypertrophic cardiomyopathy, a NGS workflow based on a panel of 48 cardiomyopathies-causing genes was analyzed on a cohort of 542 HCM patients. As expected, this molecular approach led to identify most pathogenic or likely pathogenic variants into prevalent HCM-causing genes: MYBPC3 (123/542; 22.7\%), MYH7 (48/542; 8.9\%), TNNT2 (12/542; 2.2\%), and TNNI3 (10/542; 1.8\%). Among MYBPC3 variants, 96 led to a premature stop codon (78\%). More surprisingly, our molecular study led also to detect, for the first time, homozygous CSRP3 truncating variants in two unrelated HCM probands. Meta-analysis of rare previously reported CSRP3 variants on HCM probands using ACMG guidelines indicate that only one variation (p.Cys58Gly) could be considered as likely pathogen. By combining meta-analysis results and identification of two unrelated HCM patients with homozygous CSRP3 truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an autosomal recessive inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124).},
	language = {en},
	urldate = {2020-02-11},
	journal = {Gene},
	author = {Janin, Alexandre and Bessière, Francis and Chauveau, Samuel and Chevalier, Philippe and Millat, Gilles},
	month = nov,
	year = {2018},
	keywords = {Bundle, CNV, CSRP3, Cardiology, Case Study, Custom Pipeline, Genomics, Hereditary Disorders, Hypertrophic Cardiomyopathy, INDEL, Illumina Sequencer, SNV, Targeted, cardiovascular disease},
	pages = {110--116},
}

Downloads: 0